{"PubmedBookArticle": [], "PubmedArticle": [{"MedlineCitation": {"KeywordList": [["P2Y1R", "Traditional Chinese medicines", "anti-thrombosis", "in silico screening", "platelet aggregation"]], "SpaceFlightMission": [], "InvestigatorList": [], "OtherAbstract": [], "OtherID": [], "CitationSubset": [], "GeneralNote": [], "PMID": "28119608", "DateRevised": {"Year": "2024", "Month": "05", "Day": "21"}, "Article": {"ArticleDate": [{"Year": "2017", "Month": "01", "Day": "09"}], "Language": ["eng"], "ELocationID": ["531", "10.3389/fphar.2016.00531"], "Journal": {"ISSN": "1663-9812", "JournalIssue": {"Volume": "7", "PubDate": {"Year": "2016"}}, "Title": "Frontiers in pharmacology", "ISOAbbreviation": "Front Pharmacol"}, "ArticleTitle": "<i>In silico</i> Approach for Anti-Thrombosis Drug Discovery: P2Y<sub>1</sub>R Structure-Based TCMs Screening.", "Pagination": {"StartPage": "531", "MedlinePgn": "531"}, "Abstract": {"AbstractText": ["Cardiovascular diseases (CVDs), including thrombosis, which is induced by platelet aggregation, are the leading cause of mortality worldwide. The P2Y<sub>1</sub> receptor (P2Y<sub>1</sub>R) facilitates platelet aggregation and is thus an important potential anti-thrombotic drug target. The P2Y<sub>1</sub>R protein structure contains a binding site for receptor antagonist MRS2500 within its seven-transmembrane bundle, which also provides suitable pockets for numerous other ligands to act as nucleotide antagonists of P2Y<sub>1</sub>R. The Traditional Chinese Medicine Systems Pharmacology Database and Analysis Platform (TCMSP) comprises 499 Chinese Pharmacopoeia-registered herbs and the structure information for 29,384 ingredients. <i>In silico</i> docking of these compounds into the P2Y<sub>1</sub>R protein structure within the MRS2500 pocket can identify potential antithrombotic drugs from natural medicinal plants. Docking studies were performed and scored to evaluate ligand-binding affinities. In this study, a total of 8987 compounds from Traditional Chinese Medicine (TCM) were filtered by Lipinski's rule of five, and their ideal oral-intake properties were evaluated. Of these, 1656 compounds distributed in 443 herbs docked into the P2Y<sub>1</sub>R-MRS2500 structure in 16,317 poses. A total of 38 compounds were ranked with a DockScore above 70, and these may have significant potential for development into anti-thrombosis drugs. These computational results suggested that licorice (<i>Glycyrrhiza uralensis</i> Fisch), cimicifugae (<i>Cimicifuga foetida</i> L.), and ganoderma (<i>Ganoderma lucidum</i> Karst) and their chemical constituents, which have not previously been widely used for anti-thrombosis, may have unexpected effects on platelet aggregation. Moreover, two types of triterpene scaffolds summarized from 10 compounds were distributed in these three herbs and also docked into P2Y<sub>1</sub>R. These scaffold structures may be utilized for the development of drugs to inhibit platelet aggregation."]}, "AuthorList": [{"Identifier": [], "AffiliationInfo": [{"Identifier": [], "Affiliation": "Institute of Medicinal Plant Development, Peking Union Medical College, Chinese Academy of Medical SciencesBeijing, China; Key Laboratory of Bioactive Substances and Resources Utilization of Chinese Herbal Medicine, Ministry of EducationBeijing, China."}], "LastName": "Yi", "ForeName": "Fan", "Initials": "F"}, {"Identifier": [], "AffiliationInfo": [{"Identifier": [], "Affiliation": "Institute of Medicinal Plant Development, Peking Union Medical College, Chinese Academy of Medical SciencesBeijing, China; Key Laboratory of Bioactive Substances and Resources Utilization of Chinese Herbal Medicine, Ministry of EducationBeijing, China."}], "LastName": "Sun", "ForeName": "Le", "Initials": "L"}, {"Identifier": [], "AffiliationInfo": [{"Identifier": [], "Affiliation": "Institute of Medicinal Plant Development, Peking Union Medical College, Chinese Academy of Medical SciencesBeijing, China; Key Laboratory of Bioactive Substances and Resources Utilization of Chinese Herbal Medicine, Ministry of EducationBeijing, China."}], "LastName": "Xu", "ForeName": "Li-Jia", "Initials": "LJ"}, {"Identifier": [], "AffiliationInfo": [{"Identifier": [], "Affiliation": "Institute of Medicinal Plant Development, Peking Union Medical College, Chinese Academy of Medical SciencesBeijing, China; Key Laboratory of Bioactive Substances and Resources Utilization of Chinese Herbal Medicine, Ministry of EducationBeijing, China."}], "LastName": "Peng", "ForeName": "Yong", "Initials": "Y"}, {"Identifier": [], "AffiliationInfo": [{"Identifier": [], "Affiliation": "Institute of Medicinal Plant Development, Peking Union Medical College, Chinese Academy of Medical SciencesBeijing, China; Key Laboratory of Bioactive Substances and Resources Utilization of Chinese Herbal Medicine, Ministry of EducationBeijing, China."}], "LastName": "Liu", "ForeName": "Hai-Bo", "Initials": "HB"}, {"Identifier": [], "AffiliationInfo": [{"Identifier": [], "Affiliation": "Institute of Medicinal Plant Development, Peking Union Medical College, Chinese Academy of Medical SciencesBeijing, China; Key Laboratory of Bioactive Substances and Resources Utilization of Chinese Herbal Medicine, Ministry of EducationBeijing, China."}], "LastName": "He", "ForeName": "Chun-Nian", "Initials": "CN"}, {"Identifier": [], "AffiliationInfo": [{"Identifier": [], "Affiliation": "Institute of Medicinal Plant Development, Peking Union Medical College, Chinese Academy of Medical SciencesBeijing, China; Key Laboratory of Bioactive Substances and Resources Utilization of Chinese Herbal Medicine, Ministry of EducationBeijing, China."}], "LastName": "Xiao", "ForeName": "Pei-Gen", "Initials": "PG"}], "PublicationTypeList": ["Journal Article"]}, "MedlineJournalInfo": {"Country": "Switzerland", "MedlineTA": "Front Pharmacol", "NlmUniqueID": "101548923", "ISSNLinking": "1663-9812"}}, "PubmedData": {"ReferenceList": [{"ReferenceList": [], "Reference": [{"Citation": "Afifi F. U., Abu-Dahab R. (2012). Phytochemical screening and biological activities of Eminium spiculatum (Blume) Kuntze (family Araceae). Nat. Prod. Res. 26, 878\u2013882. 10.1080/14786419.2011.565558", "ArticleIdList": ["10.1080/14786419.2011.565558", "21809948"]}, {"Citation": "Aslam M., Sedding D., Koshty A., Santoso S., Schulz R., Hamm C., et al. . (2013). Nucleoside triphosphates inhibit ADP, collagen, and epinephrine-induced platelet aggregation: role of P2Y1 and P2Y12 receptors. Phytochemistry 32, 239\u2013241. 10.1016/j.thromres.2013.08.021", "ArticleIdList": ["10.1016/j.thromres.2013.08.021", "24071464"]}, {"Citation": "Brooks B. R., Brooks C. L., III, Mackerell A. D., Jr., Nilsson L., Petrella R. J., Roux B., et al. . (2009). CHARMM: the biomolecular simulation program. J. Comput. Chem. 30, 1545\u20131614. 10.1002/jcc.21287", "ArticleIdList": ["10.1002/jcc.21287", "PMC2810661", "19444816"]}, {"Citation": "Chen K. J. (1981). Certain progress in the treatment of coronary heart disease with traditional medicinal plants in China. Am. J. Chin. Med. 9, 193\u2013196. 10.1142/S0192415X81000251", "ArticleIdList": ["10.1142/S0192415X81000251", "6307037"]}, {"Citation": "Du L., Feng X., Xiang X., Jin Y. (2016). Wound healing effect of an in situ forming hydrogel loading curcumin-phospholipid complex. Curr. Drug Deliv. 13, 76\u201382. 10.2174/1567201813666151202195437", "ArticleIdList": ["10.2174/1567201813666151202195437", "26634789"]}, {"Citation": "Gachet C. (2008). P2 receptors, platelet function and pharmacological implications. Thromb. Haemost. 99, 466\u2013472. 10.1160/th07-11-0673", "ArticleIdList": ["10.1160/th07-11-0673", "18327393"]}, {"Citation": "Gurbel P. A., Kuliopulos A., Tantry U. S. (2015). G-protein\u2013coupled receptors signaling pathways in new antiplatelet drug development. Arterioscler. Thromb. Vasc. Biol. 35, 500\u2013512. 10.1161/ATVBAHA.114.303412", "ArticleIdList": ["10.1161/ATVBAHA.114.303412", "PMC4836833", "25633316"]}, {"Citation": "Hechler B., Nonne C., Roh E. J., Cattaneo M., Cazenave J. P., Lanza F., et al. . (2006). MRS2500 [2-iodo-N6-methyl-(N)-methanocarba-2\u2032-deoxyadenosine-3\u2032,5\u2032-bisphosphate], a potent, selective, and stable antagonist of the platelet P2Y1 receptor with strong antithrombotic activity in mice. J. Pharmacol. Exp. Ther. 316, 556\u2013563. 10.1124/jpet.105.094037", "ArticleIdList": ["10.1124/jpet.105.094037", "PMC3471153", "16236815"]}, {"Citation": "Jin J., Kunapuli S. P. (1998). Coactivation of two different G protein-coupled receptors is essential for ADP-induced platelet aggregation. Proc. Natl. Acad. Sci. U.S.A. 95, 8070\u20138074. 10.1073/pnas.95.14.8070", "ArticleIdList": ["10.1073/pnas.95.14.8070", "PMC20930", "9653141"]}, {"Citation": "Karnewar S., Vasamsetti S. B., Gopoju R., Kanugula A. K., Ganji S. K., Prabhakar S., et al. . (2016). Mitochondria-targeted esculetin alleviates mitochondrial dysfunction by AMPK-mediated nitric oxide and SIRT3 regulation in endothelial cells: potential implications in atherosclerosis. Sci. Rep. 6:24108. 10.1038/srep24108", "ArticleIdList": ["10.1038/srep24108", "PMC4827087", "27063143"]}, {"Citation": "Kawagishi H., Fukuhara F., Sazuka M., Kawashima A., Mitsubori T., Tomita T. (1993). 5\u2032-deoxy-5\u2032-methylsulphinyladenosine, a platelet-aggregation inhibitor from ganoderma-lucidum. Phytochemistry 32, 239\u2013241. 10.1016/S0031-9422(00)94974-4", "ArticleIdList": ["10.1016/S0031-9422(00)94974-4"]}, {"Citation": "Kim H. S., Ohno M., Xu B., Kim H. O., Choi Y., Ji X. D., et al. . (2003). 2-Substitution of adenine nucleotide analogues containing a bicyclo [3.1.0] hexane ring system locked in a northern conformation: enhanced potency as P2Y1 receptor antagonists. J. Med. Chem. 46, 4974\u20134987. 10.1021/jm030127+", "ArticleIdList": ["10.1021/jm030127+", "PMC3408611", "14584948"]}, {"Citation": "Klupp N. L., Kiat H., Bensoussan A., Steiner G. Z., Chang D. H. (2016). A double-blind, randomised, placebo-controlled trial of Ganoderma lucidum for the treatment of cardiovascular risk factors of metabolic syndrome. Sci. Rep. 6:29540. 10.1038/srep29540", "ArticleIdList": ["10.1038/srep29540", "PMC4980683", "27511742"]}, {"Citation": "Kumaran S., Palani P., Nishanthi R., Kaviyarasan V. (2011). Studies on screening, isolation and purification of a fibrinolytic protease from an isolate (VK12) of Ganoderma lucidum and evaluation of its antithrombotic activity. Med. Mycol. J. 52, 153\u2013162. 10.3314/jjmm.52.153", "ArticleIdList": ["10.3314/jjmm.52.153", "21788727"]}, {"Citation": "Lee W., Bae J. S. (2015). Antithrombotic and antiplatelet activities of orientin in vitro and in vivo. J. Funct. Food 17, 388\u2013398. 10.1016/j.jff.2015.05.037", "ArticleIdList": ["10.1016/j.jff.2015.05.037"]}, {"Citation": "Lipinski C. A., Lombardo F., Dominy B. W., Feeney P. J. (2012). Experimental and computational approaches to estimate solubility and permeability in drug discovery and development settings. Adv. Drug Deliv. Rev. 64, 4\u201317. 10.1016/j.addr.2012.09.019", "ArticleIdList": ["10.1016/j.addr.2012.09.019", "11259830"]}, {"Citation": "Mozaffarian D., Benjamin E. J., Go A. S., Arnett D. K., Blaha M. J., Cushman M., et al. . (2016). Heart disease and stroke statistics\u20132016 update a report from the american heart association. Circulation 133, e599. 10.1161/CIR.0000000000000366", "ArticleIdList": ["10.1161/CIR.0000000000000366", "26673558"]}, {"Citation": "Ndhlala A. R., Ghebrehiwot H. M., Ncube B., Aremu A. O., Gruz J., \u0160ubrtov\u00e1 M., et al. . (2015). Antimicrobial, anthelmintic activities and characterisation of functional phenolic acids of Achyranthes aspera linn.: a medicinal plant used for the treatment of wounds and ringworm in east africa. Front. Pharmacol. 6:274. 10.3389/fphar.2015.00274", "ArticleIdList": ["10.3389/fphar.2015.00274", "PMC4655238", "26635604"]}, {"Citation": "O'Boyle N. M., Banck M., James C. A., Morley C., Vandermeersch T., Hutchison G. R. (2011). Open Babel: an open chemical toolbox. J. Cheminform. 3, 1\u201314. 10.1186/1758-2946-3-33", "ArticleIdList": ["10.1186/1758-2946-3-33", "PMC3198950", "21982300"]}, {"Citation": "Pike N. B. (2005). Flushing out the role of GPR109A (HM74A) in the clinical efficacy of nicotinic acid. J. Clin. Invest. 115, 3400\u20133403. 10.1172/JCI27160", "ArticleIdList": ["10.1172/JCI27160", "PMC1297267", "16322787"]}, {"Citation": "Radomski A., Jurasz P., Alonso-Escolano D., Drews M., Morandi M., Malinski T., et al. . (2005). Nanoparticle-induced platelet aggregation and vascular thrombosis. Brit. J. Pharmacol. 146, 882\u2013893. 10.1038/sj.bjp.0706386", "ArticleIdList": ["10.1038/sj.bjp.0706386", "PMC1751219", "16158070"]}, {"Citation": "Ru J., Li P., Wang J., Zhou W., Li B., Huang C., et al. . (2014). TCMSP: a database of systems pharmacology for drug discovery from herbal medicines. J. Cheminform. 6, 1\u20136. 10.1186/1758-2946-6-13", "ArticleIdList": ["10.1186/1758-2946-6-13", "PMC4001360", "24735618"]}, {"Citation": "Sato H., Shewchuk L. M., Tang J. (2006). Prediction of multiple binding modes of the CDK2 inhibitors, anilinopyrazoles, using the automated docking programs GOLD, FlexX, and LigandFit: an evaluation of performance. J. Chem. Inf. Model. 46, 2552\u20132562. 10.1021/ci600186b", "ArticleIdList": ["10.1021/ci600186b", "17125195"]}, {"Citation": "Tang X., Liu J., Dong W., Li P., Li L., Lin C., et al. . (2013). The cardioprotective effects of citric acid and L-malic acid on myocardial ischemia/reperfusion injury. Evid. Based Complement Alternat. Med. 2013, 1\u201311. 10.1155/2013/820695", "ArticleIdList": ["10.1155/2013/820695", "PMC3666396", "23737849"]}, {"Citation": "van de Waterbeemd H., Gifford E. (2003). ADMET in silico modelling: towards prediction paradise? Nat. Rev. Drug Discov. 2, 192\u2013204. 10.1038/nrd1032", "ArticleIdList": ["10.1038/nrd1032", "12612645"]}, {"Citation": "Yang M., Bhopale V. M., Thom S. R. (2015). Ascorbic acid abrogates microparticle generation and vascular injuries associated with high-pressure exposure. J. Appl. Physiol. 119, 77\u201382. 10.1152/japplphysiol.00183.2015", "ArticleIdList": ["10.1152/japplphysiol.00183.2015", "25977448"]}, {"Citation": "Zerr M., Hechler B., Freund M., Magnenat S., Lanois I., Cazenave J. P., et al. . (2011). Major contribution of the P2Y1 receptor in purinergic regulation of TNF \u03b1-induced vascular inflammation. Circulation 123, 2404\u20132413. 10.1161/CIRCULATIONAHA.110.002139", "ArticleIdList": ["10.1161/CIRCULATIONAHA.110.002139", "21576651"]}, {"Citation": "Zhang D., Gao Z. G., Zhang K., Kiselev E., Crane S., Wang J., et al. . (2015). Two disparate ligand-binding sites in the human P2Y1 receptor. Nature 520, 317\u2013321. 10.1038/nature14287", "ArticleIdList": ["10.1038/nature14287", "PMC4408927", "25822790"]}]}], "History": [{"Year": "2016", "Month": "6", "Day": "13"}, {"Year": "2016", "Month": "12", "Day": "22"}, {"Year": "2017", "Month": "1", "Day": "26", "Hour": "6", "Minute": "0"}, {"Year": "2017", "Month": "1", "Day": "26", "Hour": "6", "Minute": "0"}, {"Year": "2017", "Month": "1", "Day": "26", "Hour": "6", "Minute": "1"}, {"Year": "2017", "Month": "1", "Day": "9"}], "PublicationStatus": "epublish", "ArticleIdList": ["28119608", "PMC5220089", "10.3389/fphar.2016.00531"]}}]}